JP2004519440A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519440A5
JP2004519440A5 JP2002550986A JP2002550986A JP2004519440A5 JP 2004519440 A5 JP2004519440 A5 JP 2004519440A5 JP 2002550986 A JP2002550986 A JP 2002550986A JP 2002550986 A JP2002550986 A JP 2002550986A JP 2004519440 A5 JP2004519440 A5 JP 2004519440A5
Authority
JP
Japan
Prior art keywords
core
benazepril
pharmaceutically acceptable
pharmaceutical composition
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002550986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519440A (ja
Filing date
Publication date
Priority claimed from PCT/US2000/034246 external-priority patent/WO2002049645A1/en
Application filed filed Critical
Publication of JP2004519440A publication Critical patent/JP2004519440A/ja
Publication of JP2004519440A5 publication Critical patent/JP2004519440A5/ja
Withdrawn legal-status Critical Current

Links

JP2002550986A 2000-12-18 2001-12-17 アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ Withdrawn JP2004519440A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/034246 WO2002049645A1 (en) 2000-12-18 2000-12-18 Therapeutic combination of amlodipine and benazepril
PCT/US2001/048808 WO2002049646A1 (en) 2000-12-18 2001-12-17 Therapeutic combination of amlodipine and benazepril/benazeprilat

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009235225A Division JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ

Publications (2)

Publication Number Publication Date
JP2004519440A JP2004519440A (ja) 2004-07-02
JP2004519440A5 true JP2004519440A5 (https=) 2005-12-22

Family

ID=21742073

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002550985A Pending JP2004516266A (ja) 2000-12-18 2000-12-18 アムロジピンおよびベナゼブリルの治療的組み合わせ
JP2002550986A Withdrawn JP2004519440A (ja) 2000-12-18 2001-12-17 アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ
JP2009235225A Pending JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002550985A Pending JP2004516266A (ja) 2000-12-18 2000-12-18 アムロジピンおよびベナゼブリルの治療的組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009235225A Pending JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ

Country Status (26)

Country Link
EP (3) EP1365761A1 (https=)
JP (3) JP2004516266A (https=)
KR (3) KR20040007420A (https=)
CN (2) CN1461218A (https=)
AT (1) ATE338549T1 (https=)
AU (4) AU2581601A (https=)
BR (2) BR0017386A (https=)
CA (2) CA2432638A1 (https=)
CY (1) CY1106275T1 (https=)
CZ (2) CZ20031678A3 (https=)
DE (1) DE60122928T2 (https=)
DK (1) DK1345607T3 (https=)
EC (1) ECSP034658A (https=)
ES (1) ES2272565T3 (https=)
HU (2) HUP0302455A3 (https=)
IL (4) IL156136A0 (https=)
MX (2) MXPA03005462A (https=)
NO (2) NO20032766L (https=)
NZ (1) NZ526467A (https=)
PL (2) PL362252A1 (https=)
PT (1) PT1345607E (https=)
RU (1) RU2292206C2 (https=)
SI (1) SI1345607T1 (https=)
SK (2) SK7652003A3 (https=)
WO (2) WO2002049645A1 (https=)
ZA (1) ZA200304514B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467095A1 (en) * 2001-11-23 2003-05-30 Solvay Pharmaceuticals Gmbh Hypertonia treatment during the acute phase of a cerebrovascular accident
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
MXPA05011371A (es) 2003-04-25 2005-12-01 Novacardia Inc Metodo para mejorar la diuresis en individuos con la funcion renal deteriorada.
TW200524591A (en) * 2003-10-20 2005-08-01 Novartis Ag Use of organic compounds
WO2005074927A1 (en) * 2004-02-09 2005-08-18 Novartis Ag Therapeutic combination of amlodipine and benazepril/ benazeprilat for the treatment of hypertension
WO2005079772A2 (en) * 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
WO2006085208A2 (en) * 2005-02-11 2006-08-17 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine and benazepril
WO2006092732A2 (en) * 2005-03-04 2006-09-08 Aurobindo Pharma Ltd Stable solid dosage form of antihypertensive agent
AU2006224161A1 (en) 2005-03-15 2006-09-21 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
WO2007040511A1 (en) * 2005-09-28 2007-04-12 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
DK1797885T3 (da) * 2005-09-28 2008-07-14 Teva Pharma Stabil kombination af amlodipinbesylat og benazeprilhydrochlorid
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
IT1398168B1 (it) * 2010-02-16 2013-02-14 Chiesi Farma Spa Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.
EP2585051B2 (en) 2010-06-23 2020-04-08 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
CN102389431A (zh) * 2011-09-28 2012-03-28 济南龙华医药技术有限公司 一种含有盐酸贝尼地平和盐酸贝那普利的复方制剂及其应用
AU2012357795B2 (en) 2011-12-21 2017-04-06 Elanco Tiergesundheit Ag New combination
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
WO2014035707A1 (en) * 2012-08-25 2014-03-06 The Johns Hopkins University Gapdh cascade inhibitor compounds and methods of use and treatment of stress induced disorders including mental illness
EP3021832B9 (en) 2013-07-19 2023-03-15 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CA2930033C (en) 2013-12-04 2022-12-13 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
CN108778334A (zh) * 2016-03-24 2018-11-09 第三共株式会社 用于治疗肾脏疾病的药物
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
UA124884C2 (uk) 2016-11-16 2021-12-08 Лундбек Ла Джолла Ресеарч Центер, Інк. Фармацевтичні склади
MA46866B1 (fr) 2016-11-16 2021-11-30 H Lundbeck As Une forme cristalline d'un inhibiteur de magl

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
JPH11500140A (ja) * 1995-03-16 1999-01-06 ファイザー・インコーポレーテッド アムロジピン、アムロジピン塩、もしくはフェロジピンとａｃｅ阻害薬とを含有する組成物
TR199701121T1 (xx) * 1995-04-07 1998-03-21 Novartis Ag Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Similar Documents

Publication Publication Date Title
JP2004519440A5 (https=)
RU2003121019A (ru) Терапевтическая композиция амлодипина и беназеприла/беназеприлата
ES2380704T3 (es) Metanosulfonato de éster etílico de ácido 3-[(2-{[4-(hexiloxicarbonilamino--imino-metil)-fenilamino]-metil}-1-metil-1H-bencimidazol-5-carb3onil)-piridin-2-il-amino]-propiónico
JP5162689B2 (ja) 活性成分としてのパントプラゾールを含有する投与形
US20070237820A1 (en) Pharmaceutical formulations containing a non-steroidal antinflammatory drug and an antiulcerative drug
PL187074B1 (pl) Doustna farmaceutyczna postać dawkowana, sposób wytwarzania doustnej farmaceutycznej postaci dawkowanej i zastosowanie doustnej farmaceutycznej postaci dawkowanej
JP2009544752A (ja) アムロジピン及びロサルタンを含む薬剤学的組成物
KR101875112B1 (ko) 암로디핀, 발사르탄 및 로수바스타틴을 포함하는 약학적 조성물
TWI388316B (zh) 抑制胃酸分泌之組合物及方法
KR102369607B1 (ko) 암로디핀 및 로잘탄을 포함하는 고형 약제학적 조성물
RU2012112051A (ru) Препараты ингибиторы тромбообразования
WO2013013351A1 (zh) 复方甲氧那明的速释-缓释渗透泵制剂
TW202103697A (zh) 包含依澤替米貝(ezetimibe)及洛沙坦(losartan)之藥學組合製劑
EA032808B1 (ru) Дозированная лекарственная форма, содержащая бисопролол и периндоприл
CA2620018A1 (en) Stable combinations of amlodipine besylate and benazepril hydrochloride
CN102488691B (zh) 一种治疗或预防高血压或由高血压所引起的疾病的药物制剂
TWI734046B (zh) 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑
KR20110031226A (ko) 에프로사르탄 조성물
EP1797885B1 (en) Stable combinations of amlodipine besylate and benazepril hydrochloride
KR20090107961A (ko) 심혈관계 질환 치료용 약제학적 제제
US20150374713A1 (en) Stable pharmeceutical composition of amlodipine and benazepril or salts thereof
HK1103658B (en) Stable combinations of amlodipine besylate and benazepril hydrochloride
KR20090021222A (ko) 수분 민감성 약물 및 제2 약물의 배합을 포함하는 안정한 제제 및 이의 제조 방법
HK1059566B (en) Therapeutic combination of amlodipine and benazepril/benazeprilat
HK1117073A (en) Sable composition of benazepril hydrochloride